Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder

The severity of the ongoing opioid crisis, recently exacerbated by the COVID-19 pandemic, emphasizes the importance for individuals suffering from opioid use disorder (OUD) to have access to and receive efficacious, evidence-based treatments. Optimal treatment of OUD should aim at blocking the effec...

Full description

Bibliographic Details
Main Authors: Celine M. Laffont, Eliford Ngaimisi, Mathangi Gopalakrishnan, Vijay Ivaturi, Malcolm Young, Mark K. Greenwald, Christian Heidbreder
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Pharmacology
Subjects:
(extended-release) buprenorphine
opioid blockade
withdrawal
craving
exposure-response
opioid use disorder
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1052113/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.1052113/full

Similar Items